Kishi Yoji, Madoff David C, Abdalla Eddie K, Palavecino Martin, Ribero Dario, Chun Yun Shin, Vauthey Jean-Nicolas
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030-4009, USA.
Surgery. 2008 Nov;144(5):744-51. doi: 10.1016/j.surg.2008.05.015. Epub 2008 Aug 10.
Preoperative portal vein embolization (PVE) is increasingly used as a preparation for major hepatectomy in patients with inadequate liver remnant volume or function. However, whether segment 4 (S4) portal veins should be embolized is controversial. The effect of S4 PVE on the volume gain of segments 2 and 3 (S2+3) was examined.
Among 73 patients with uninjured liver who underwent right portal vein embolization (RPVE, n = 15) or RPVE extended to S4 portal veins (RPVE+4, n = 58), volume changes in S2+3 and S4 after embolization were compared. Clinical outcomes and PVE complications were assessed.
After a median of 27 days, the S2+3 volume increased significantly after both RPVE and RPVE+4, but the absolute increase was significantly higher for RPVE+4 (median, 106 mL vs 141 mL; P = .044), as was the hypertrophy rate (median, 26% vs 54%; P = .021). There was no significant difference between RPVE and RPVE+4 in the absolute S4 volume increase (52 mL for RPVE vs 55 mL for RPVE+4; P = .61) or the hypertrophy rate of S4 (30% for RPVE vs 26% for RPVE+4; P = .45). Complications of PVE occurred in 1 patient (7%) after RPVE and 6 (10%) after RPVE+4 (P > .99). No PVE complication precluded subsequent resection. Curative hepatectomy was performed in 13 patients (87%) after RPVE and 40 (69%) after RPVE+4 (P = .21).
RPVE+4 significantly improves S2+3 hypertrophy compared with RPVE alone. Extending RPVE to S4 does not increase PVE-associated complications.
术前门静脉栓塞术(PVE)越来越多地用于肝残余体积或功能不足患者的肝大部切除术的准备。然而,是否应栓塞4段(S4)门静脉存在争议。本研究探讨了S4 PVE对2段和3段(S2+3)体积增加的影响。
在73例未受伤肝脏且接受了右门静脉栓塞术(RPVE,n = 15)或扩展至S4门静脉的RPVE(RPVE+4,n = 58)的患者中,比较栓塞后S2+3和S4的体积变化。评估临床结局和PVE并发症。
中位27天后,RPVE和RPVE+4后S2+3体积均显著增加,但RPVE+4的绝对增加量显著更高(中位数,106 mL对141 mL;P = 0.044),肥大率也是如此(中位数,26%对54%;P = 0.021)。RPVE和RPVE+4在S4绝对体积增加量(RPVE为52 mL,RPVE+4为55 mL;P = 0.61)或S(30%对26%;P = 0.45)方面无显著差异。RPVE后1例患者(7%)发生PVE并发症,RPVE+4后6例(10%)发生(P > 0.99)。没有PVE并发症妨碍后续切除。RPVE后13例患者(87%)进行了根治性肝切除术,RPVE+4后40例(69%)进行了根治性肝切除术(P = 0.21)。
与单独的RPVE相比,RPVE+4显著改善了S2+3肥大。将RPVE扩展至S4不会增加PVE相关并发症。